» Articles » PMID: 38203771

The Effect of Cross-Sex Fecal Microbiota Transplantation on Metabolism and Hormonal Status in Adult Rats

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Jan 11
PMID 38203771
Authors
Affiliations
Soon will be listed here.
Abstract

Increasing evidence of sexual dimorphism in the pathophysiology of metabolic complications caused by sex steroids is under investigation. The gut microbiota represents a complex microbial ecosystem involved in energy metabolism, immune response, nutrition acquisition, and the health of host organisms. Gender-specific differences in composition are present between females and males. The purpose of this study was to use cross-sex fecal microbiota transplantation (FMT) for the detection of sex-dependent metabolic, hormonal, and gut microbiota changes in female and male recipients. Healthy non-obese female and male Wistar rats were divided into donor, same-sex, and cross-sex recipient groups. After a 30-day period of FMT administration, biochemical markers (glucose and lipid metabolism) and sex hormones were measured, and the gut microbiota was analyzed. The cross-sex male recipients displayed a significantly lower testosterone concentration compared to the males that received same-sex FMT. Sex-dependent changes caused by cross-sex FMT were detected, while several bacterial taxa correlated with plasma testosterone levels. This study represents the first to study the effect of cross-sex changes in the gut microbiome concerning metabolic and hormonal changes/status in adult non-obese Wistar rats. Herein, we present cross-sex FMT as a potential tool to modify sex-specific pathologies.

Citing Articles

The Legalome: Microbiology, Omics and Criminal Justice.

Logan A, Mishra P, Prescott S Microb Biotechnol. 2025; 18(3):e70129.

PMID: 40072296 PMC: 11898878. DOI: 10.1111/1751-7915.70129.


The influence of seminal microbiota on human testicular steroidogenesis: a prospective study.

Cannarella R, Curto R, Condorelli R, Grillo A, Aversa A, Calogero A J Assist Reprod Genet. 2025; .

PMID: 39776388 DOI: 10.1007/s10815-024-03351-y.

References
1.
Chi J, Lin P, Tolstikov V, Oyekunle T, Chen E, Bussberg V . Metabolomic effects of androgen deprivation therapy treatment for prostate cancer. Cancer Med. 2020; 9(11):3691-3702. PMC: 7286468. DOI: 10.1002/cam4.3016. View

2.
Gao A, Su J, Liu R, Zhao S, Li W, Xu X . Sexual dimorphism in glucose metabolism is shaped by androgen-driven gut microbiome. Nat Commun. 2021; 12(1):7080. PMC: 8648805. DOI: 10.1038/s41467-021-27187-7. View

3.
Gilbert J, Jansson J, Knight R . The Earth Microbiome project: successes and aspirations. BMC Biol. 2014; 12:69. PMC: 4141107. DOI: 10.1186/s12915-014-0069-1. View

4.
Aggeletopoulou I, Konstantakis C, Assimakopoulos S, Triantos C . The role of the gut microbiota in the treatment of inflammatory bowel diseases. Microb Pathog. 2019; 137:103774. DOI: 10.1016/j.micpath.2019.103774. View

5.
Allan C, Strauss B, Burger H, Forbes E, McLachlan R . Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. J Clin Endocrinol Metab. 2007; 93(1):139-46. DOI: 10.1210/jc.2007-1291. View